How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies.

ABSTRACT: Patients with hematologic malignancies are particularly vulnerable to COVID-19 infections, and upon a pooled data analysis of 24 publications, there is evidence that they have suboptimal antibody responses to COVID-19 vaccination and boosters. To provide them the needed additional protection from COVID-19, it is imperative to achieve a 100% full immunization rate in health care workers and adult caretakers, and to foster research to test higher doses and repeated rounds of COVID-19 vaccines and the use of passive immune prophylaxis and therapy.

SUBMITTER: Ribas A 

PROVIDER: S-EPMC8580613 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature